Lidocaine ophthalmic gel
Alternative Names: AK-1015; Akten; Lidocaine ophthalmicLatest Information Update: 20 Jan 2022
At a glance
- Originator Akorn
- Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaesthesia
Most Recent Events
- 16 Oct 2008 Launched for Local anaesthesia in USA (Ophthalmic) (First global launch)
- 09 Oct 2008 Registered for Local anaesthesia in USA (Ophthalmic)
- 04 Jun 2008 Akorn receives approvable letter from the FDA for AK 1015 in Local anaesthesia